文献速递关节外科

二期翻修治疗假体周围感染期间抗生素耐药性的出现

Emergence of Antibiotic Resistance Across Two-Stage Revision for Periprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2021-04-15

该研究回顾性分析了142例慢性培养阳性假体周围感染(PJI)患者,均接受二期翻修。仅7.04%的患者在二期翻修期间出现抗生素耐药。再植入时17.6%培养阳性,其中16例为新微生物,9例为原微生物。结论认为该队列中未出现主要耐药 emergence。

要点

  • 二期翻修期间抗生素耐药出现率低(7.04%)。
  • 再植入时17.6%培养阳性,新微生物占多数。
  • 全程持续感染10.56%,新感染17.6%,一年内再感染18.3%。

核心结论

  • 在该队列中,接受二期翻修和抗生素治疗的患者未出现主要抗生素耐药微生物的涌现。

研究设计与样本

  • 回顾性综述2014年1月至2019年5月142例慢性培养阳性PJI接受二期翻修患者的临床记录。

主要发现

  • 142例中仅10例(7.04%)在二期翻修期间出现抗生素耐药。
  • 再植入时25例(17.6%)培养阳性,其中16例为新微生物,9例为原微生物。
  • 全程中15例(10.56%)持续感染,25例(17.6%)新感染,26例(18.3%)一年内同一关节再感染。

关键数值与推荐

  • 耐药依据微生物实验室报告和最低抑菌浓度定义。

临床怎么用

  • 二期翻修治疗慢性PJI时抗生素耐药 emergence 不常见,但仍需监测培养结果。

局限性

  • 回顾性设计,单中心,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current preferred treatment for chronic hip and knee periprosthetic joint infection (PJI) involves both surgical intervention and antibiotic treatment as part of a two-stage revision. The purpose of this study is to determine how often patients who underwent a two-stage revision for chronic PJI developed a subsequent antibiotic-resistant infection. METHODS: We retrospectively reviewed the clinical records of 142 patients who underwent a two-stage revision for a chronic culture-positive PJI from January 2014 to May 2019. Demographic data and risk factors for PJI were identified. Resistance was defined in accordance with microbiology laboratory report and minimum inhibitory concentration. Statistical analysis consisted of descriptive statistics and univariate analysis. RESULTS: Only 10 of the 142 patients (7.04%) demonstrated emergence of resistance to antibiotics across their two-stage revision. At reimplantation, 25 (17.6%) patients had positive cultures. Of these, 16 patients presented with a novel organism and 9 patients had positive culture for the same organism as the initial infection. During the entire course of the two-stage revision, including spacer exchanges and irrigation and debridement procedures, 15 (10.56%) patients demonstrated persistent infections, whereas 25 (17.6%) patients presented with novel infections. 26 (18.3%) patients had reinfection of the same joint within one year. CONCLUSION: In the given cohort, there does not appear to be a major emergence of antibiotic resistant organisms in patients undergoing two-stage exchange arthroplasty and antibiotic treatment.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ludwick L, Chisari E, Wang J, et al. Emergence of Antibiotic Resistance Across Two-Stage Revision for Periprosthetic Joint Infection. J Arthroplasty. 2021. PMID: 33934949. doi:10.1016/j.arth.2021.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。